Michael ZürcherNov 2, 20221 min readThree reasons why pharmaceutical companies should consider the Swiss healthcare market
Michael ZürcherOct 24, 20221 min readTEAM & PARTNERSSwizzard co-founds SMS2DACH network together with MArS (Germany) and Supersonic (Austria)
Michael ZürcherOct 19, 20224 min readSWIZZARD CHAMPIONS"Health markets are becoming the drivers of a new economic era."
Michael ZürcherSep 14, 20224 min readINSIGHTSSwizzard Insight No. 5: How to bring medical breakthroughs to Switzerland faster
Michael ZürcherAug 25, 20221 min readTEAM & PARTNERSSwizzard welcomes Arne Holicki as Business Technology Leader
Michael ZürcherJun 14, 20221 min readCOMPANY NEWSSwizzard’s celebrating an exciting milestone – we just signed our 10th client!
Michael ZürcherMay 11, 20221 min readTEAM & PARTNERSMeet David Hoffmann, member of the Board of Directors & Corporate Secretary of Swizzard Pharma AG
Michael ZürcherMar 30, 20224 min readSWIZZARD CHAMPIONS“The more firms there are, the more candidates move to Switzerland and the more attractive it gets"
